Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use

Author： Chiodelli Paola   Bugatti Antonella   Urbinati Chiara   Rusnati Marco  

Publisher： MDPI

E-ISSN： 1420-3049|20|4|6342-6388

ISSN： 1420-3049

Source： Molecules, Vol.20, Iss.4, 2015-04, pp. : 6342-6388

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic Regulation of the Biosynthesis Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers

By Hull Elizabeth E.   Montgomery McKale R.   Leyva Kathryn J.  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-06 ,pp. : 1361-1361

MDPI

Access to resources Recommend Favorite

Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?

By Farrugia Brooke L.   Lord Megan S.   Melrose James   Whitelock John M.  

Molecules, Vol. 20, Iss. 3, 2015-03 ,pp. : 4254-4276

MDPI

Access to resources Recommend Favorite

Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors

By Kim Ha Na   Whitelock John M.   Lord Megan S.  

Molecules, Vol. 22, Iss. 5, 2017-05 ,pp. : 806-806

MDPI

Access to resources Recommend Favorite

Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily

By Rider Chris C.   Mulloy Barbara  

Molecules, Vol. 22, Iss. 5, 2017-04 ,pp. : 713-713

MDPI

Access to resources Recommend Favorite

Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders

By Mizumoto Shuji   Kosho Tomoki   Yamada Shuhei   Sugahara Kazuyuki  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-03 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite